ORACLE-VHT: Preparatory Actions for an EU-HORIZON call on Virtual Human Twins in Cancer – Towards Personalized Management of Pancreatic Cancer
| Reference number | |
| Coordinator | Linköpings universitet |
| Funding from Vinnova | SEK 500 000 |
| Project duration | May 2026 - September 2026 |
| Status | Ongoing |
| Call | Planning grant for international proposal 2026 |
Important results from the project
The project achieved its main objective: the preparation and successful submission of the Horizon Europe proposal ORACLE-VHT, focused on development of Virtual Human Twin technologies for pancreatic cancer. The project also enabled expansion and maturation of a multidisciplinary international network of clinical, academic, industry and patient-representative partners, formation of new collaborations future connection to major national and European research initiatives.
Expected long term effects
The project has established a strong international platform for future research and innovation in AI-driven cancer care and Virtual Human Twin technologies. It strengthens Sweden´s position in a leadership role within emerging European initiatives focused on health data, AI and precision medicine. In the longer term, the resulting partnerships, methodologies and infrastructure may support more individualized cancer care, broader international collaborations and future digital-health innovations.
Approach and implementation
The project was carried out through international consortium building, stakeholder engagement, scientific and technical project development, and collaborative proposal writing. Prospective partners were recruited continuously and integrated into consortium activities. Two workshops, in June and August, were central to defining and refining the project structure, work packages and strategy. The project followed the planned timeline, and collaboration functioned very well throughout.